Clinical Study
Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana
Table 1
Characteristics of 233 HIV-infected children on highly active antiretroviral therapy (HAART) from 2004–2009, Accra, Ghana.
| Characteristics | (%) |
| Age category | | <1 year | 10 (4.3) | 1–5 years | 118 (51.0) | >6 years | 105 (45.1) | Gender | | Female | 112 (48.1) | Male | 121 (51.9) | Immune recovery | | No | 61 (26.2) | Yes | 172 (73.8) | WHO immune classification | | No evidence of suppression | 31 (13.3) | Evidence of moderate suppression | 80 (34.3) | Sever suppression | 122 (52.4) | WHO clinical staging | | I | 33 (14.1) | II | 53 (22.7) | III | 106 (45.5) | IV | 41 (17.6) | Previous TB diagnosis and treatment | | Yes | 119 (51.1) | No | 114 (48.9) | Graduate of PMTCT program | | Yes | 3 (1.3) | No | 203 (87.1) | Do not know | 27 (11.6) | Mode of transmission | | Vertical | 199 (85.4) | Indeterminate | 11 (4.7) | Do not know | 23 (9.9) | Self report of adherence | | Poor | 13 (5.6) | Good | 46 (19.8) | Excellent | 144 (61.8) | Unknown | 30 (12.9) | Parental HIV status | | Both parents HIV-positive | 28 (12.0) | Only one parent HIV-positive | 128 (54.9) | Both parents unknown status | 75 (32.2) | Mother unknown and father HIV-negative | 2 (0.9) | Parental living status | | Both parents alive | 109 (46.8) | One parent known alive | 79 (33.9) | Both parents dead | 23 (9.9) | Both parents unknown | 8 (3.4) | One parent alive and other unknown | 14 (6.0) |
|
|